← Back to Search

Audit and Feedback for Suicide

N/A
Waitlist Available
Led By Nazanin H. Bahraini, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from month 9 of intervention phase 1 and month 9 of intervention phase 2
Awards & highlights

Study Summary

This trial aims to improve how the Veterans Health Administration screens and evaluates patients for suicide risk in ambulatory care settings.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from month 9 of intervention phase 1 and month 9 of intervention phase 2
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from month 9 of intervention phase 1 and month 9 of intervention phase 2 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Columbia Suicide Severity Rating Scale Screener (C-SSRS) Uptake
Comprehensive Suicide Risk Evaluation (CSRE) Uptake
Other outcome measures
Implementation Climate Scale
Implementation Leadership Scale
Safety Planning Uptake

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: External FacilitationExperimental Treatment2 Interventions
Audit and Feedback plus External Facilitation will serve as the second stage implementation intervention for sites that still do not meet the benchmark for adequate implementation following 9 months of implementation as usual plus audit and feedback.
Group II: Audit and FeedbackExperimental Treatment1 Intervention
Audit and Feedback will serve as the first stage implementation intervention for sites that do not meet the benchmark for adequate implementation following 9 months of implementation as usual.
Group III: Implementation as UsualActive Control1 Intervention
Implementation support consisting of clinical decision support tools, trainings, technical assistance and quality assurance to support implementation of VA Suicide Risk Identification Strategy. Available to all facilities.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Audit and Feedback
2016
N/A
~85530
External Facilitation
2021
N/A
~140

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,466 Total Patients Enrolled
38 Trials studying Suicide
5,480 Patients Enrolled for Suicide
Nazanin H. Bahraini, PhDPrincipal InvestigatorRocky Mountain Regional VA Medical Center, Aurora, CO

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for individuals to join this trial?

"The trial's status on clinicaltrials.gov reports that the recruitment period for this medical study has ended, with its first post dated April 14th 2021 and last updated October 6th 2022. Despite this, there are still 171 other trials actively recruiting patients at present time."

Answered by AI
~34 spots leftby Apr 2025